This is a preview of subscription content, log in via an institution to check access.
Notes
epidermal growth factor receptor
References
Behl AS, et al. Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. Journal of the National Cancer Institute : 28 Nov 2012. Available from: URL: http://dx.doi.org/10.1093/jnci/djs433
Carlson JJ, et al. Proof or Principle? On Economic Modeling to Guide Genomic Testing in Metastatic Colorectal Cancer. Journal of the National Cancer Institute : 28 Nov 2012. Available from: URL: http://dx.doi.org/10.1093/jnci/djs476
Rights and permissions
About this article
Cite this article
Screening before providing cetuximab cost saving. PharmacoEconomics & Outcomes News 669, 6 (2013). https://doi.org/10.1007/s40274-013-0053-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0053-y